Dr. Collins is a postdoctoral fellow in Dr. Ravi Majeti’s lab at Stanford University and a senior clinical fellow in the Hematology and Oncology Department. Following her undergraduate studies at Williams College, Dr. Collins received her MD/PhD degree at the University of Michigan, where she worked with Dr. Jay Hess studying the role of collaborator proteins in HOXA9-mediated leukemic transformation. Her current research focuses on understanding mechanisms of preleukemic transformation in acute myeloid leukemia (AML) by prospectively modeling mutation acquisition in human hematopoietic stem cells. Throughout her training, Dr. Collins has remained passionate about her career as a physician-scientist, which presents the opportunity to care for patients with hematologic malignancies in the clinic, while also studying these diseases in the lab. Her ultimate goal is to identify a safe and well-tolerated therapy to selectively eradicate preleukemic stem cells and block the formation of AML.